🔎 Trials Near Me

Home › Waldenstrom Macroglobulinemia › Massachusetts › Boston

Waldenstrom Macroglobulinemia clinical trials in Boston, MA

9 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

RecruitingPhase 2
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
  • Beth Israel Deaconess Medical Center (Data Collection Only), Boston
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07231952

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06561347

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

RecruitingPhase 4
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07426484

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

RecruitingObservational study
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT02269592

Epcoritamab in Previously Treated WM

RecruitingPhase 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT06510491

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1
  • Beth Israel Deaconess Medical Center, Boston
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

RecruitingPhase 2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Dec 5, 2025 · NCT06986174

Waldenstrom Macroglobulinemia trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.